Questions discussed in this category
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
If so, you have a recommended tapering strategy?
In what patient populations would you consider using disulfiram (Antabuse) instead of, or in addition to, acamprosate or naltrexone? In your experienc...
Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.
2493526247261672508725746237852326723705
Papers discussed in this category
Journal of addiction medicine, 2021 May-Jun 01
The American journal on addictions, 2023 Mar 20
Drug and alcohol dependence, 2024 Sep 07
JAMA psychiatry, 2025 Apr 01
JHEP reports : innovation in hepatology, 2024 Apr 10